• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Physicians' Attitudes and Practices Regarding Cannabis and Recommending Medical Cannabis Use.医生对大麻的态度和实践以及推荐医用大麻的使用。
Cannabis Cannabinoid Res. 2024 Aug;9(4):e1048-e1055. doi: 10.1089/can.2022.0324. Epub 2023 Apr 25.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Sexual Harassment and Prevention Training性骚扰与预防培训
4
Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence.父母及非正式照料者关于儿童常规疫苗接种沟通的观点与经历:定性证据综述
Cochrane Database Syst Rev. 2017 Feb 7;2(2):CD011787. doi: 10.1002/14651858.CD011787.pub2.
5
Do Surgeons Experience Moral Dissonance When There Is Misalignment Between Evidence and Action? A Survey and Scenario-based Study.当证据与行动不一致时,外科医生会经历道德失调吗?一项基于调查和情景的研究。
Clin Orthop Relat Res. 2025 Feb 1;483(2):217-224. doi: 10.1097/CORR.0000000000003220. Epub 2024 Aug 7.
6
A Comprehensive and Modality Diverse Cervical Spine and Back Musculoskeletal Physical Exam Curriculum for Medical Students.面向医学生的全面且多模态的颈椎和背部肌肉骨骼物理检查课程
J Educ Teach Emerg Med. 2025 Jul 31;10(3):SG1-SG8. doi: 10.21980/J8RQ0N. eCollection 2025 Jul.
7
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
8
Can We Enhance Shared Decision-making for Periacetabular Osteotomy Surgery? A Qualitative Study of Patient Experiences.我们能否加强髋臼周围截骨术的共同决策?一项关于患者体验的定性研究。
Clin Orthop Relat Res. 2025 Jan 1;483(1):120-136. doi: 10.1097/CORR.0000000000003198. Epub 2024 Jul 23.
9
Cannabis and schizophrenia.大麻与精神分裂症。
Cochrane Database Syst Rev. 2014 Oct 14;2014(10):CD004837. doi: 10.1002/14651858.CD004837.pub3.
10
"Like the Wild West": Health care provider perspectives on impacts of recreational cannabis legalization on patients and providers at a tertiary psychiatric hospital in Ontario, Canada.“像狂野西部一样”:加拿大安大略省一家三级精神病医院的卫生保健提供者对娱乐性大麻合法化对患者和提供者影响的看法。
J Subst Use Addict Treat. 2024 Dec;167:209487. doi: 10.1016/j.josat.2024.209487. Epub 2024 Aug 15.

引用本文的文献

1
Medicinal and combined medicinal/recreational cannabis use in California following the passage of Proposition 64.加利福尼亚州第64号提案通过后医用大麻及医用/娱乐用大麻的联合使用情况
J Cannabis Res. 2025 Jul 12;7(1):44. doi: 10.1186/s42238-025-00285-9.
2
Physicians' Knowledge, Attitudes, and Perceptions about Medical Cannabis in the United States: A Scoping Review.美国医生对医用大麻的知识、态度和看法:一项范围综述
Med Cannabis Cannabinoids. 2025 May 14;8(1):58-64. doi: 10.1159/000546264. eCollection 2025 Jan-Dec.
3
Does Cannabis Use Contribute to Schizophrenia? A Causation Analysis Based on Epidemiological Evidence.使用大麻会导致精神分裂症吗?基于流行病学证据的因果关系分析。
Biomolecules. 2025 Mar 4;15(3):368. doi: 10.3390/biom15030368.
4
Adverse events caused by cannabinoids in middle aged and older adults for all indications: a meta-analysis of incidence rate difference.大麻素在所有适应症导致的中老年成年人不良事件:发病率差异的荟萃分析。
Age Ageing. 2024 Nov 1;53(11). doi: 10.1093/ageing/afae261.
5
Patient-provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study.关于大麻用于治疗目的的医患互动因提供者类型而异:一项试点研究。
Am J Addict. 2025 May;34(3):277-288. doi: 10.1111/ajad.13656. Epub 2024 Oct 24.
6
Cannabis-related information sources among US residents: A probability-weighted nationally representative survey.美国居民中与大麻相关的信息来源:一项概率加权的全国代表性调查。
J Cannabis Res. 2024 Oct 1;6(1):38. doi: 10.1186/s42238-024-00249-5.
7
Canadians' use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status.自娱乐用大麻合法化以来,加拿大人出于治疗目的使用大麻的情况:按医疗授权状况进行的横断面分析。
BMC Med. 2024 Apr 8;22(1):150. doi: 10.1186/s12916-024-03370-7.
8
Knowledge and Attitudes of Cannabidiol in Croatia among Students, Physicians, and Pharmacists.克罗地亚学生、医生和药剂师对大麻二酚的了解与态度
Pharmacy (Basel). 2023 Dec 23;12(1):2. doi: 10.3390/pharmacy12010002.

本文引用的文献

1
Oncology Fellows' Clinical Discussions, Perceived Knowledge, and Formal Training Regarding Medical Cannabis Use: A National Survey Study.肿瘤学研究员临床讨论、感知知识和医学大麻使用方面的正式培训:一项全国性调查研究。
JCO Oncol Pract. 2022 Nov;18(11):e1762-e1776. doi: 10.1200/OP.21.00714. Epub 2022 Apr 8.
2
Emergency Medicine Physicians Would Prefer Using Cannabis Over Opioids for First-Line Treatment of a Medical Condition if Provided With Medical Evidence: A National Survey.一项全国性调查:如果有医学证据,急诊医学医生在对某种病症进行一线治疗时会更倾向于使用大麻而非阿片类药物。
Cureus. 2021 Nov 16;13(11):e19641. doi: 10.7759/cureus.19641. eCollection 2021 Nov.
3
Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC.消费者对δ-8-四氢大麻酚的体验:医疗用途、药物替代以及与δ-9-四氢大麻酚的比较
Cannabis Cannabinoid Res. 2023 Feb;8(1):166-173. doi: 10.1089/can.2021.0124. Epub 2021 Nov 19.
4
Physicians' experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review.医生对医用大麻的经验、态度和信念:系统文献综述。
BMC Fam Pract. 2021 Oct 21;22(1):212. doi: 10.1186/s12875-021-01559-w.
5
Analysis of State Cannabis Laws and Dispensary Staff Recommendations to Adults Purchasing Medical Cannabis.分析州内大麻法律和大麻药房工作人员向购买医用大麻的成年人提出的建议。
JAMA Netw Open. 2021 Sep 1;4(9):e2124511. doi: 10.1001/jamanetworkopen.2021.24511.
6
Assessing Health Care Providers' Knowledge of Medical Cannabis.评估医疗保健提供者对医用大麻的认知。
Cannabis Cannabinoid Res. 2022 Aug;7(4):501-507. doi: 10.1089/can.2021.0032. Epub 2021 Aug 31.
7
Cannabis and Migraine: It's Complicated.大麻与偏头痛:错综复杂。
Curr Pain Headache Rep. 2021 Feb 25;25(3):16. doi: 10.1007/s11916-020-00931-2.
8
Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution.医疗服务提供者与医用大麻患者之间关于转诊和药物替代的沟通。
J Cannabis Res. 2021 Jan 24;3(1):2. doi: 10.1186/s42238-021-00058-0.
9
A content analysis of internet information sources on medical cannabis.对医用大麻网络信息来源的内容分析。
J Cannabis Res. 2020 Sep 18;2(1):29. doi: 10.1186/s42238-020-00041-1.
10
Perioperative Cannabis as a Potential Solution for Reducing Opioid and Benzodiazepine Dependence.围手术期大麻作为减少阿片类药物和苯二氮䓬类药物依赖的潜在解决方案。
JAMA Surg. 2021 Feb 1;156(2):181-190. doi: 10.1001/jamasurg.2020.5545.

医生对大麻的态度和实践以及推荐医用大麻的使用。

Physicians' Attitudes and Practices Regarding Cannabis and Recommending Medical Cannabis Use.

机构信息

Population Studies Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA.

Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.

出版信息

Cannabis Cannabinoid Res. 2024 Aug;9(4):e1048-e1055. doi: 10.1089/can.2022.0324. Epub 2023 Apr 25.

DOI:10.1089/can.2022.0324
PMID:37098170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11538087/
Abstract

Medical cannabis users tend not to trust or rely on health care providers regarding cannabis advice. Previous surveys of physicians have focused on favorability toward medical cannabis. The current study assesses how physicians interact with patients regarding cannabis in their day-to-day practice, and whether and how they address important topics such as use patterns and substituting cannabis for medications. We predicted that physicians would generally perceive cannabis dispensary staff and caretakers as not competent in addressing patient health needs and would not be likely to use their recommendations. Physicians in a university-affiliated health system completed an anonymous online survey. The survey assessed physicians' cannabis related education experiences, perceptions of their knowledge of and competence regarding medical cannabis, and the content of cannabis related discussions with patients. We also examined perceptions of the sources of influence on patients regarding cannabis and physicians' attitudes toward medical cannabis dispensary staff and medical cannabis caregivers (MCCs). A few physicians (10%) had ever signed a medical cannabis authorization form for their patients, consistent with their perceptions of low knowledge and competence in this area. Discussions on cannabis primarily focus on risks (63%) rather than dosage (6%) and harm reduction (25%). Physicians see their influence on patients as weak compared with other information sources and have generally unfavorable attitudes toward medical cannabis dispensary staff and MCCs. Greater integration of medical cannabis knowledge is needed at all levels of medical and clinical education to address the potential harm to patients if they receive no guidance. Continued research is needed to provide a strong scientific basis for developing treatment guidelines and standardized medical education for medical cannabis use.

摘要

医用大麻使用者往往不信任或依赖医疗保健提供者提供的有关大麻的建议。以前对医生的调查主要集中在对医用大麻的支持程度上。目前的研究评估了医生在日常实践中如何与患者就大麻进行互动,以及他们是否以及如何解决重要问题,如使用模式和用大麻替代药物。我们预测,医生通常会认为大麻药房工作人员和护理人员在解决患者健康需求方面能力不足,不太可能接受他们的建议。在一所大学附属医疗系统工作的医生完成了一项匿名在线调查。该调查评估了医生的大麻相关教育经验、他们对医用大麻的了解和能力的看法,以及与患者进行的大麻相关讨论的内容。我们还研究了影响患者对大麻看法的来源以及医生对医用大麻药房工作人员和医用大麻护理人员(MCCs)的态度。只有少数医生(10%)曾为患者签署过医用大麻授权书,这与他们在这方面知识和能力较低的看法一致。关于大麻的讨论主要集中在风险(63%)而不是剂量(6%)和减少伤害(25%)上。与其他信息来源相比,医生认为他们对患者的影响力较弱,对医用大麻药房工作人员和 MCCs 的态度普遍不佳。需要在医疗和临床教育的各个层面上加强医用大麻知识的整合,以避免患者在得不到指导的情况下受到伤害。需要继续研究,为制定治疗指南和标准化医用大麻使用的医学教育提供强有力的科学依据。